TY - DATA T1 - Data underlying the manuscript: An eHealth intervention to support patients with a low socioeconomic position during their waiting period preceding cardiac rehabilitation: a randomised controlled feasibility study. PY - 2024/04/05 AU - Jasper Faber AU - Jos Kraal AU - Nienke ter Hoeve AU - Isra Al-Dhahir AU - Linda Breeman AU - Niels Chavannes AU - Andrea Evers AU - Hans Bussmann AU - Rita van den Berg-Emons UR - DO - 10.4121/c7e2a63a-9699-4d7c-9cbb-9ac443400033.v3 KW - Cardiac rehabilitation KW - low socioeconomic position KW - eHealth intervention KW - waiting period N2 -

This data repository contains the research data from the study: An eHealth intervention to support patients with a low socioeconomic position during their waiting period preceding cardiac rehabilitation: a randomised controlled feasibility study. The research was carried out between February 2023 and September 2023.


This study employed a mixed methods randomized controlled feasibility approach, targeting low SEP patients eligible for CR, dividing them into an intervention group, which received an eHealth intervention, and a control group, which underwent the standard waiting period. The study assessed feasibility through adherence (using usage metrics) and acceptance (using a modified USE questionnaire), along with the intervention's effect on participants' certainty and guidance through a self-designed CGQ, complemented by semi-structured interviews for qualitative insights. Non-parametric statistical. The CGQ's effect analysis involved Wilcoxon rank-sum, Mann-Whitney U, and Spearman's rank correlation tests. The ATLAS.ti software was used for qualitative analysis.

The dataset includes the study protocol, participant consent forms, questionnaires for research data collection, an interview guide, quantitative data files, and R scripts for data analysis, alongside a presentation file for initial participant meetings. Other files address the ethics approval, consent form, questionnaire, and semi-structured interview guide. Privacy-sensitive information have been excluded for confidentiality.

The study is registered at ClinicalTrials.gov (NCT05698121) and received ethical approval from the Medisch Ethische Toetsings Commissie of the Erasmus Medical Centre (approval number MEC-2022-0483).

ER -